Indian brothers lose appeal over pharma award
The Singapore Court of Appeal has upheld a US$530 million ICC award that found Indian brothers Malvinder and Shivinder Mohan Singh liable for fraud over the sale of a pharmaceutical business.
To read more
Subscribe to Global Arbitration Review
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Arbitration Review experts.